Study of Sulfasalazine in Treating Painful Neuropathy
Status:
Terminated
Trial end date:
2017-08-10
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that sulfasalazine, an FDA-approved medication for rheumatoid
arthritis and ulcerative colitis, may be beneficial in neuropathic pain conditions. In this
study, the investigators will evaluate whether sulfasalazine improves pain due to painful
peripheral neuropathy.